NCT00791258
A Dose Escalation Study of a Combination Antihypertensive Drug in the Treatment of Various Groups of Patients Who do Not Respond to Single Drug Treatment of Their High Blood Pressure
See it on ClinicalTrials.gov ↗999 people
49.1%
50.9%
491 womenmiddle line = equal numbers508 men
- Phase
- PHASE4
- Paid for by
- Daiichi Sankyo
- Finished
- 2009-09
- Health conditions
- Hypertension
- Who could join
- Anyone
- Ages
- 18 Years – no maximum
- Average age
- Not reported
- Age 65+
- 22.8%
- Weight (BMI)
- mean 31.02 Kg/m٨2
- Pregnancy recorded
- Not reported
- Menopause recorded
- Not reported
- Results shown by sex
- Not split by sex
- Race
- White 63.1% · Black / African American 23.4% · Asian 12.9% · American Indian / Alaska Native 0.6% · Native Hawaiian / Pacific Islander 0% · More than one race 0% · Not reported 0%
Women left out
- No pregnant women
Women who were pregnant could not join.
“Pregnant females”
- Had to use birth control
Women who couldn't or didn't want to use birth control were turned away.
“post menopausal or have had a hysterectomy or tubal ligation or practicing approved methods of birth control”
- No heart disease
Women with heart disease, heart rhythm problems or a past heart attack were turned away.
“History of myocardial infarction, bypass graft, angioplasty or heart failure within the past 6 months”
- No diabetes
Women with diabetes were turned away.
“Diabetes requiring insulin”
Study titles and rules are shown in their original English.